Literature DB >> 19770680

High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: the role of the renin-angiotensin-aldosterone system.

Yehuda Kamari1, Nir Shimoni, Faina Koren, Edna Peleg, Yehonatan Sharabi, Ehud Grossman.   

Abstract

BACKGROUND: High sodium intake is associated with increased risk of end-organ damage, independent of blood pressure (BP) levels. The protective peptide adiponectin may play a role in the pathogenesis of hypertension and particularly in salt-loaded conditions. Furthermore, increased adiponectin levels were observed in salt-loaded conditions. However, there is little information on the direct effect of high-salt diet on plasma adiponectin. The aim of the present study was to examine the effect of high-salt diet on adiponectin levels in Sprague-Dawley rats and explore the mechanisms that regulate adiponectin levels under salt loading.
METHODS: Sprague-Dawley rats were fed either standard chow diet or medium or high sodium diet for 5 weeks. BP and plasma adiponectin were measured at baseline and during the study. In additional studies the same protocol was repeated with the addition of clonidine, telmisartan, hydralazine or eplerenone.
RESULTS: High-salt diet increased systolic BP, suppressed plasma aldosterone levels and attenuated body weight gain. Five weeks of salt loading increased plasma adiponectin levels in a dose-dependent manner (medium salt and high salt were 47 and 93% higher than control, respectively, P < 0.05). Hydralazine and clonidine attenuated salt-induced BP increase but did not attenuate the increase in adiponectin levels whereas, telmisartan, an angiotensin receptor blocker, and eplerenone, an aldosterone blocker, attenuated both the increase in BP and in adiponectin levels.
CONCLUSIONS: High salt intake increases adiponectin levels independent of the increase in BP. This effect is mediated through the renin-angiotensin-aldosterone system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19770680     DOI: 10.1097/HJH.0b013e3283325eee

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

Review 1.  Advances in the neurophysiology of magnocellular neuroendocrine cells.

Authors:  Jeffrey G Tasker; Masha Prager-Khoutorsky; Ryoichi Teruyama; José R Lemos; William E Amstrong
Journal:  J Neuroendocrinol       Date:  2020-02-05       Impact factor: 3.627

2.  Association of adiponectin with left ventricular mass in blacks: the Jackson Heart Study.

Authors:  Aurelian Bidulescu; Jiankang Liu; Solomon K Musani; Ervin R Fox; Tandaw E Samdarshi; Daniel F Sarpong; Viola Vaccarino; Peter W Wilson; Donna K Arnett; Rebecca Din-Dzietham; Herman A Taylor; Gary H Gibbons
Journal:  Circ Heart Fail       Date:  2011-08-12       Impact factor: 8.790

3.  The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men.

Authors:  Anand Vaidya; John P Forman; Patricia C Underwood; Paul N Hopkins; Gordon H Williams; Luminita H Pojoga; Jonathan S Williams
Journal:  Eur J Endocrinol       Date:  2011-03-14       Impact factor: 6.664

4.  Interaction between Adiponectin and Aldosterone.

Authors:  Colleen Flynn; George L Bakris
Journal:  Cardiorenal Med       Date:  2011-04-15       Impact factor: 2.041

Review 5.  Adipokines and blood pressure control.

Authors:  Frederique Yiannikouris; Manisha Gupte; Kelly Putnam; Lisa Cassis
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-03       Impact factor: 2.894

6.  Association of adiponectin with type 2 diabetes and hypertension in African American men and women: the Jackson Heart Study.

Authors:  Sharon K Davis; Samson Y Gebreab; Ruihua Xu; Pia Riestra; Rumana J Khan; Anne E Sumner; DeMarc Hickson; Aurelian Bidulescu
Journal:  BMC Cardiovasc Disord       Date:  2015-02-25       Impact factor: 2.298

7.  Genetic variants in adiponectin and blood pressure responses to dietary sodium or potassium interventions: a family-based association study.

Authors:  C Chu; Y Wang; K-Y Ren; D-Y Yan; T-S Guo; W-L Zheng; Z-Y Yuan; J-J Mu
Journal:  J Hum Hypertens       Date:  2016-03-24       Impact factor: 3.012

8.  Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study.

Authors:  Chang-Yun Yoon; Yung Ly Kim; Seung Hyeok Han; Tae-Hyun Yoo; Su-Ah Sung; Woo-Kyung Chung; Dong-Wan Chae; Yong-Soo Kim; Curie Ahn; Kyu Hun Choi
Journal:  Diabetol Metab Syndr       Date:  2016-11-14       Impact factor: 3.320

9.  The association of two polymorphisms in adiponectin-encoding gene with hypertension risk and the changes of circulating adiponectin and blood pressure: A meta-analysis.

Authors:  Jianmin Wu; Guoyan Xu; Wenqin Cai; Yun Huang; Ningyu Xie; Yihua Shen; Liangdi Xie
Journal:  Oncotarget       Date:  2017-02-28

10.  Longitudinal associations between adiponectin and cardiac structure differ by hypertensive status: Coronary Artery Risk Development in Young Adults.

Authors:  Shishir Sharma; Laura A Colangelo; Donald Lloyd-Jones; David R Jacobs; Myron D Gross; Samuel S Gidding; Philip Greenland
Journal:  Cardiovasc Endocrinol       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.